198 related articles for article (PubMed ID: 32194720)
1. Secretagogin, a marker for neuroendocrine cells, is more sensitive and specific in large cell neuroendocrine carcinoma compared with the markers CD56, CgA, Syn and Napsin A.
Dong Y; Li Y; Liu R; Li Y; Zhang H; Liu H; Chen J
Oncol Lett; 2020 Mar; 19(3):2223-2230. PubMed ID: 32194720
[TBL] [Abstract][Full Text] [Related]
2. SOX11 is a sensitive and specific marker for pulmonary high-grade neuroendocrine tumors.
Yu L; Dong Y; Xue J; Xu S; Wang G; Kuang D; Duan Y
Diagn Pathol; 2022 Jan; 17(1):2. PubMed ID: 34996493
[TBL] [Abstract][Full Text] [Related]
3. Utility of secretagogin as a marker for the diagnosis of lung neuroendocrine carcinoma.
Baykara Y; Xiao Y; Yang D; Yakirevich E; Maleki S; Garcia-Moliner M; Wang LJ; Huang CK; Lu S
Virchows Arch; 2022 Jul; 481(1):31-39. PubMed ID: 35357570
[TBL] [Abstract][Full Text] [Related]
4. Expression and clinical significance of a new neuroendocrine marker secretagogin in cervical neuroendocrine carcinoma.
Yu L; Suye S; Huang R; Liang Q; Fu C
J Clin Pathol; 2021 Dec; 74(12):787-795. PubMed ID: 33060116
[TBL] [Abstract][Full Text] [Related]
5. Expression and Clinicopathological Significance of SOX11 in Small-Cell Lung Cancer.
Xinli W; Lixiao W; Baoqi D; Hu H; Qiang Z
Biomed Res Int; 2022; 2022():1707914. PubMed ID: 35402616
[TBL] [Abstract][Full Text] [Related]
6. Secretagogin is a new neuroendocrine marker in the human prostate.
Adolf K; Wagner L; Bergh A; Stattin P; Ottosen P; Borre M; Birkenkamp-Demtröder K; Orntoft TF; Tørring N
Prostate; 2007 Apr; 67(5):472-84. PubMed ID: 17285592
[TBL] [Abstract][Full Text] [Related]
7. Secretagogin, a novel neuroendocrine marker, has a distinct expression pattern from chromogranin A.
Lai M; Lü B; Xing X; Xu E; Ren G; Huang Q
Virchows Arch; 2006 Oct; 449(4):402-9. PubMed ID: 16955307
[TBL] [Abstract][Full Text] [Related]
8. The Clinical Significance of Neuroendocrine Features in Invasive Breast Carcinomas.
Lai BS; Tsang JY; Poon IK; Shao Y; Chan SK; Tam FK; Cheung SY; Shea KH; Tse GM
Oncologist; 2020 Sep; 25(9):e1318-e1329. PubMed ID: 32472950
[TBL] [Abstract][Full Text] [Related]
9. Application of INSM1 in Diagnosis and Grading of Laryngeal Neuroendocrine Carcinoma.
Yuan C; Jiao F; Zhai C; Zhang J; Wang S; Zhu L
Laryngoscope; 2021 Oct; 131(10):E2662-E2668. PubMed ID: 33847383
[TBL] [Abstract][Full Text] [Related]
10. [Location and functions of secretagogin protein].
Liu Q; Lai M
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 Jan; 45(1):56-60. PubMed ID: 27045242
[TBL] [Abstract][Full Text] [Related]
11. Distinct clinicopathologic features, genomic characteristics and survival of central and peripheral pulmonary large cell neuroendocrine carcinoma: From different origin cells?
Zhou F; Hou L; Ding T; Song Q; Chen X; Su C; Li W; Gao G; Ren S; Wu F; Fan J; Wu C; Zhang J; Zhou C
Lung Cancer; 2018 Feb; 116():30-37. PubMed ID: 29413048
[TBL] [Abstract][Full Text] [Related]
12. Insulinoma-associated protein 1 is a sensitive and specific marker of neuroendocrine lung neoplasms in cytology specimens.
Doxtader EE; Mukhopadhyay S
Cancer Cytopathol; 2018 Apr; 126(4):243-252. PubMed ID: 29360191
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary Large Cell Neuroendocrine Carcinoma.
Yang L; Fan Y; Lu H
Pathol Oncol Res; 2022; 28():1610730. PubMed ID: 36304941
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of the aberrant expression of neuroendocrine markers in melanomas.
Wu Y; Lai Y; Zhang M; Li Z
Diagn Pathol; 2021 Aug; 16(1):78. PubMed ID: 34454530
[TBL] [Abstract][Full Text] [Related]
15. High grade neuroendocrine lung tumors: pathological characteristics, surgical management and prognostic implications.
Grand B; Cazes A; Mordant P; Foucault C; Dujon A; Guillevin EF; Barthes FLP; Riquet M
Lung Cancer; 2013 Sep; 81(3):404-409. PubMed ID: 23769675
[TBL] [Abstract][Full Text] [Related]
16. DLL3 expression in large cell neuroendocrine carcinoma (LCNEC) and association with molecular subtypes and neuroendocrine profile.
Hermans BCM; Derks JL; Thunnissen E; van Suylen RJ; den Bakker MA; Groen HJM; Smit EF; Damhuis RA; van den Broek EC; ; Ruland A; Speel EJM; Dingemans AMC
Lung Cancer; 2019 Dec; 138():102-108. PubMed ID: 31678831
[TBL] [Abstract][Full Text] [Related]
17. [Clinical Analysis of 22 Cases of Pulmonary Large Cell Neuroendocrine Cancer].
Qian Z; Hu Y; Zheng H; Dong Y; Wang Q; Li B
Zhongguo Fei Ai Za Zhi; 2016 Feb; 19(2):82-7. PubMed ID: 26903161
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of clinicopathological features of intestinal neuroendocrine neoplasms].
Gao W; Liu SM; Lu HZ; Liang J; Yuan YL; Liu XY
Zhonghua Zhong Liu Za Zhi; 2012 Jun; 34(6):450-6. PubMed ID: 22967448
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of four neuroendocrine markers in small cell neuroendocrine carcinomas of the cervix: a meta-analysis.
Huang R; Yu L; Zheng C; Liang Q; Suye S; Yang X; Yin H; Ren Z; Shi L; Zhang Z; Chen H; Fu C
Sci Rep; 2020 Sep; 10(1):14975. PubMed ID: 32917946
[TBL] [Abstract][Full Text] [Related]
20. [Pulmonary neuroendocrine tumors in the new WHO 2015 classification: Start of breaking new grounds?].
Schnabel PA; Junker K
Pathologe; 2015 May; 36(3):283-92. PubMed ID: 25956813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
